Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The YES-associated protein–transcriptional enhancer factor domain complex (YAP–TEAD) is a key transcriptional regulator involved in cell proliferation, growth, and survival. YAP, a transcriptional co-activator, interacts with TEAD transcription factors to promote the expression of genes involved in these processes. The activity of YAP is regulated by the Hippo signaling pathway, with phosphorylation leading to cytoplasmic retention and degradation, while dephosphorylation allows nuclear translocation and TEAD binding. Dysregulation of the YAP-TEAD complex is implicated in various cancers, making it a potential therapeutic target.
Inhibition of YAP-TEAD interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YES-associated protein–transcriptional enhancer factor domain complex.